pubmed.ncbi.nlm.nih.gov

Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies - PubMed

️Wed Jan 01 2020

Review

Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies

Massimo E Maffei. Int J Mol Sci. 2020.

Abstract

Fibromyalgia (FM) is a syndrome that does not present a well-defined underlying organic disease. FM is a condition which has been associated with diseases such as infections, diabetes, psychiatric or neurological disorders, rheumatic pathologies, and is a disorder that rather than diagnosis of exclusion requires positive diagnosis. A multidimensional approach is required for the management of FM, including pain management, pharmacological therapies, behavioral therapy, patient education, and exercise. The purpose of this review is to summarize the recent advances in classification criteria and diagnostic criteria for FM as well as to explore pharmacotherapy and the use of alternative therapies including the use of plant bioactive molecules.

Keywords: alternative therapies; diagnosis; fibromyalgia; natural products; pharmacotherapy; plant extracts.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest

Figures

**Figure 1**
Widespread Pain Index from ACR 1990 criteria for the classification of fibromyalgia and related regions.

**Figure 2**
Symptom Severity scale (SSS) and Extent of Somatic Symptoms (ESS).

**Figure 3**
Structure formulae of some cannabinoids and related compounds. Numbers correspond to compound names cited in the text.

**Figure 4**
Structure formulae of some opioids and related compounds. Numbers correspond to molecules cited in the text.

**Figure 5**
Structure formulae of some gabapentinoids. Numbers correspond to molecules cited in the text.

**Figure 6**
Chemical structure of some serotonin and noradrenaline reuptake inhibitors and a tricyclic antidepressant. Numbers correspond to molecules cited in the text.

**Figure 7**
Chemical structure of some natural compounds with antinociceptive activity.

Cited by

Fibromyalgia: A Review of the Pathophysiological Mechanisms and Multidisciplinary Treatment Strategies.
Jurado-Priego LN, Cueto-Ureña C, Ramírez-Expósito MJ, Martínez-Martos JM. Jurado-Priego LN, et al. Biomedicines. 2024 Jul 11;12(7):1543. doi: 10.3390/biomedicines12071543. Biomedicines. 2024. PMID: 39062116 Free PMC article. Review.
Research Trends of Acupuncture Therapy for Chronic Pain-Related Depression or Anxiety from 2003 to 2023: A Bibliometric Analysis.
Yang P, Wang T, He YJ, Su SY. Yang P, et al. J Pain Res. 2023 Dec 15;16:4301-4315. doi: 10.2147/JPR.S436434. eCollection 2023. J Pain Res. 2023. PMID: 38116394 Free PMC article.
The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders.
Stasiłowicz-Krzemień A, Nogalska W, Maszewska Z, Maleszka M, Dobroń M, Szary A, Kępa A, Żarowski M, Hojan K, Lukowicz M, Cielecka-Piontek J. Stasiłowicz-Krzemień A, et al. Int J Mol Sci. 2024 May 25;25(11):5749. doi: 10.3390/ijms25115749. Int J Mol Sci. 2024. PMID: 38891938 Free PMC article. Review.
AKAP12 and RNF11 as Diagnostic Markers of Fibromyalgia and Their Correlation with Immune Infiltration.
Lin X, Zhang K, Meng T. Lin X, et al. Oxid Med Cell Longev. 2022 Oct 4;2022:9033342. doi: 10.1155/2022/9033342. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36238643 Free PMC article.
Analysis of the Influence of IL-6 and the Activation of the Jak/Stat3 Pathway in Fibromyalgia.
Marino Y, Arangia A, Cordaro M, Siracusa R, D'Amico R, Impellizzeri D, Cupi R, Peritore AF, Gugliandolo E, Fusco R, Cuzzocrea S, Di Paola R. Marino Y, et al. Biomedicines. 2023 Mar 6;11(3):792. doi: 10.3390/biomedicines11030792. Biomedicines. 2023. PMID: 36979771 Free PMC article.

References

1. Wang S.M., Han C., Lee S.J., Patkar A.A., Masand P.S., Pae C.U. Fibromyalgia diagnosis: A review of the past, present and future. Expert Rev. Neurother. 2015;15:667–679. doi: 10.1586/14737175.2015.1046841. - DOI - PubMed
1. Chinn S., Caldwell W., Gritsenko K. Fibromyalgia pathogenesis and treatment options update. Curr. Pain Headache Rep. 2016;20:25. doi: 10.1007/s11916-016-0556-x. - DOI - PubMed
1. Blanco I., Beritze N., Arguelles M., Carcaba V., Fernandez F., Janciauskiene S., Oikonomopoulou K., de Serres F.J., Fernandez-Bustillo E., Hollenberg M.D. Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin. Rheumatol. 2010;29:1403–1412. doi: 10.1007/s10067-010-1474-7. - DOI - PubMed
1. Cabo-Meseguer A., Cerda-Olmedo G., Trillo-Mata J.L. Fibromyalgia: Prevalence, epidemiologic profiles and economic costs. Med. Clin. 2017;149:441–448. doi: 10.1016/j.medcli.2017.06.008. - DOI - PubMed
1. Williams D.A., Schilling S. Advances in the assessment of fibromyalgia. Rheum. Dis. Clin. N. Am. 2009;35:339–357. doi: 10.1016/j.rdc.2009.05.007. - DOI - PMC - PubMed

Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies - PubMed